IndiaInfoline » Markets » JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd - Share Price

JAGSNPHARM

Open

81.95

Prev. Close

82.15

Turnover (lac.)

266

Day's High

84.80

Day's Low

81.60

52 Week's High

102.00

52 Week's Low

17.80

Book Value

44

Face Value

5

Mkt Cap (Cr.)

218

P/E

16.15

EPS

5.16

Divi. Yield

0.6

Jagsonpal Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Jagsonpal Pharmaceuticals LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd643.0051.49152,825.64555.550.633,366.01106.10
Divis Laboratories Ltd3,789.0053.5899,581.25461.240.431,656.48313.47
Dr Reddys Laboratories Ltd4,807.0033.2979,151.17443.700.523,397.50979.36
Cipla Ltd944.0026.7571,154.26698.930.453,689.88233.60
Aurobindo Pharma Ltd844.8018.5455,292.10740.510.323,701.14246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Jagsonpal Pharmaceuticals LtdSummary & Reports

No Company Summary found

Registered Office

T-210 J,Shahpur Jat,New Delhi, New Delhi,110049

Tell. : +91-011-46181100/46109900
Website : http://www.jagsonpal.com
Email : cs@jagsonpal.com

Registrar Office

F-65 1st Floor, Phase-I, New Delhi-110020 INDIA

Tell. : +91-11-41406149-52
Website : www.mcsdel.com
Email : mcsdel@vsnl.com

Reports by jagsonpal-pharmaceuticals-ltd-share-price

Latest Release by jagsonpal-pharmaceuticals-ltd-share-price

View

- <

Reco. Price

Jul 01,2020 02:48 PM

Target Price

Target Returns:

0.00%

Result Express

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    12 Feb 2021

    Annc. Date

    03 Feb 2021

    JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More

  • Purpose

    Board Meeting

    Exp. Date

    10 Nov 2020

    Annc. Date

    02 Nov 2020

    JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More